Plus Therapeutics, Inc. (PSTV)

6.47 +0.47 (+7.83%) USD  |  NASDAQ  |  May 07, 09:41
More

Plus Therapeutics SG&A Expense (TTM) : 12.13M for Dec. 31, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for PSTV.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Abbott Laboratories 13.01B
Accuray, Inc. 88.55M
Alphatec Holdings, Inc. 371.51M
Boston Scientific Corp. 7.072B
Apyx Medical Corp. 22.11M